Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health, Reducing Psychiatric Hospitalizations and Work Absences April 28, 2026 Rebecca Shoemaker New, large-scale research involving nearly 100,000 individuals has unveiled a significant correlation between the use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic, Wegovy, and Rybelsus),…
Psychology & Intimacy GLP-1 Medications Show Significant Promise in Improving Mental Health Outcomes April 20, 2026 Rebecca Shoemaker New, large-scale research conducted by an international consortium of scientists has revealed a compelling link between the use of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, commonly prescribed for type 2 diabetes…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study April 13, 2026 Rebecca Shoemaker New research spearheaded by an international consortium of scientists is shedding light on a potential, and perhaps unexpected, benefit of GLP-1 receptor agonists, a class of medications widely recognized for…
Psychology & Intimacy Psilocybin Derivatives Show Promise for Psychedelic-Inspired Therapies with Reduced Hallucinations April 11, 2026 Rebecca Shoemaker Psilocybin, the naturally occurring psychoactive compound in "magic mushrooms," has emerged as a significant area of scientific inquiry, holding considerable therapeutic potential for a spectrum of mental health and neurological…
Psychology & Intimacy GLP-1 Medications Show Remarkable Links to Improved Mental Health Outcomes, New Large-Scale Study Reveals April 6, 2026 Rebecca Shoemaker Groundbreaking research conducted by an international consortium of scientists from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia has unveiled a significant association between…
Psychology & Intimacy GLP-1 Medications Show Significant Promise for Improving Mental Health Outcomes, New Large-Scale Study Reveals March 30, 2026 Rebecca Shoemaker A groundbreaking international study, pooling data from nearly 100,000 individuals, has unveiled a compelling link between the use of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, commonly prescribed for type 2 diabetes…
Psychology & Intimacy GLP-1 Medications Show Significant Promise for Improving Mental Health Outcomes March 22, 2026 Rebecca Shoemaker New research published in the esteemed journal The Lancet Psychiatry has unveiled a compelling link between glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications primarily known for their efficacy…
SexTech & Future Tech Narcissistic Individuals Show Higher Intent to Purchase Self-Replicated Sex Robots, Study Finds March 21, 2026 Nila Kartika Wati A groundbreaking study has revealed a significant correlation between high narcissism scores and a greater intention to purchase sex robots explicitly modeled on one’s own physical likeness. This intriguing finding…
